Monogram Biosciences, Inc.

Monogram is a leader in developing and commercializing innovative products to help guide and improve the treatment of infectious diseases, cancer and other serious diseases. Our molecular diagnostics and testing services enable: Healthcare providers to optimize treatment regimens for their patients to lead to better outcomes and reduced costs by matching the underlying molecular elements of an individual patient's disease to the drug best able to affect those elements; and Pharmaceutical companies to develop new and improved antiviral therapeutics and vaccines as well as targeted cancer therapeutics more efficiently by providing enhanced patient selection and monitoring capabilities throughout the development process

Contact Details: 345 Oyster Point Blvd South San Francisco California 94080-1913 United States of America Tel: (650) 635-1100 Fax: Email: customerservice@monogrambio.com WWW: www.aclara.com/

Loading...

Press Releases on Monogram Biosciences, Inc.:
New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance	12th June, 2009	Quest Diagnostics Incorporated	Faster reporting aids physicians in identifying HIV mutations that can inhibit effectiveness of newest class of antiretroviral therapy MADISON, N.J., June 12 /PRNewswire-FirstCall/ -- Quest
PDL BioPharma Appoints Karen J. Wilson as Vice President, Finance and Principal Accounting Officer	29th April, 2009	PDL BioPharma, Inc.	- Company Updates Board of Directors Audit Committee Members and Complies with Nasdaq Rule - INCLINE VILLAGE, Nev., April 29 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today
Monogram Announces 2008 Third Quarter Financial Results	27th October, 2008	Monogram Biosciences, Inc.	SOUTH SAN FRANCISCO, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (Nasdaq: MGRM) today reported financial results for the quarter ended September 30, 2008. The Company
Monogram Announces a 6-to-1 Reverse Stock Split	27th October, 2008	Monogram Biosciences, Inc.	SOUTH SAN FRANCISCO, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc., (Nasdaq: MGRM) today announced that its Board of Directors has approved a 6-to-1 reverse split of its
Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay	26th October, 2008	Monogram Biosciences, Inc.	SOUTH SAN FRANCISCO, Calif., Oct. 26 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (Nasdaq: MGRM) announced today that data presented this week demonstrated that in Pfizer Inc's (NYSE: PFE

BioNews Results for Monogram Biosciences, Inc.:
LabCorp is Scheduled to Present at the Credit Suisse 18th Annual Healthcare Conference	Yahoo! Canada:  Nov 6 2009 3:02PM Matching: monogram biosciences inc
Monogram Biosciences Inc-Financial Company Report - research report released	PR inside:  Nov 2 2009 8:50AM Matching: monogram biosciences inc
Marc J. Fagel of the U.S. Securities and Exchange Commission to Discuss SEC Enforcement at CBI's Biotech/Pharm	TickerTech.com:  Oct 8 2009 3:58AM Matching: monogram biosciences inc
Marc J. Fagel of the U.S. Securities and Exchange Commission to Discuss SEC Enforcement at CBI's Biotech/Pharm	Financials.com:  Oct 7 2009 8:46PM Matching: monogram biosciences inc
Marc J. Fagel of the U.S. Securities and Exchange Commission to Discuss SEC Enforcement at CBI's Biotech/Pharm	KOTA Territory News:  Oct 7 2009 2:37PM Matching: monogram biosciences inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Monogram Biosciences, Inc. news.

Monogram Biosciences, Inc. Patents:
US Patent No.	Title
7579143	Method of assessing the effectiveness of a non-nucleoside reverse transcriptase inhibitor (NNRTI) on a human immunodeficiency virus type 1 (HIV-1)-infected patient
7247439	Method of evaluating a patient antibody response to envelope proteins of a virus
7235356	Methods of evaluating cell surface receptor binding of a patient derived population of viral envelope protein constructs
7186506	Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
7169551	Methods of evaluating viral entry inhibitors using patient derived envelope protein constructs
→View more Monogram Biosciences, Inc. patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 391 times since April 2007, the link to the organisation's website has been followed 67 times

Search for more companies in South San Francisco

Search for more companies in California

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Monogram Biosciences, Inc.